123P Patient-Derived Explant Cultures (PDECs) as a model system for immuno-oncology studies
ConclusionOur data support our hypothesis that PDECs retain a similar immunocontexture as the original tumors, and can be interrogated with immunomodulatory compounds relevant to current immunotherapies.Legal entity responsible for the studyThe authors.FundingAcademy of Finland, Juselius Foundation, Cancer Organisations.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Finland Health | Immunotherapy | Legislation | Study